Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Rakovina Therapeutics Inc. has announced that some debenture holders have chosen to receive common shares instead of cash as part of their interest payment, amounting to approximately $20,500. The issuance of these shares is contingent upon the discounted market price and necessary approvals from the TSX Venture Exchange.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue